Key Client Fiduciary Advisors, LLC Leap Therapeutics, Inc. Transaction History

Key Client Fiduciary Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 25, 2023	BUY	$0.29 - $0.72 $54,083 - $134,276	186,495 Added 13.82%	1,535,816 $522,000
Q4 2022 Jan 17, 2023	BUY	$0.42 - $9.18 $95,918 - $2.1 Million	228,378 Added 20.37%	1,349,321 $0
Q3 2022 Oct 12, 2022	BUY	$0.92 - $9.3 $56,342 - $569,550	61,242 Added 5.78%	1,120,943 $986,000
Q2 2022 Jul 19, 2022	BUY	$0.96 - $1.91 $337,796 - $672,073	351,871 Added 49.71%	1,059,701 $1.22 Million
Q1 2022 Apr 18, 2022	BUY	$1.6 - $3.35 $318,160 - $666,147	198,850 Added 39.07%	707,830 $1.24 Million
Q4 2021 Mar 01, 2022	BUY	$2.08 - $3.65 $1.06 Million - $1.86 Million	508,980 New	508,980 $1.65 Million

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $254M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of Key Client Fiduciary Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Key Client Fiduciary Advisors, LLC with notifications on news.